This report is classified TOP SECRET and requires Level 3 clearance for access.
The results of the MUKD-482 project suggest that NS-12 is a promising candidate for cognitive enhancement. The observed improvements in cognitive function are consistent with the proposed mechanism of action, which involves modulation of neural pathways and neurotransmitter systems.